Success Metrics

Clinical Success Rate
81.3%

Based on 26 completed trials

Completion Rate
81%(26/32)
Active Trials
8(10%)
Results Posted
15%(4 trials)
Terminated
6(8%)

Phase Distribution

Ph phase_2
20
26%
Ph phase_3
2
3%
Ph early_phase_1
5
6%
Ph phase_1
46
59%
Ph not_applicable
5
6%

Phase Distribution

51

Early Stage

20

Mid Stage

2

Late Stage

Phase Distribution78 total trials
Early Phase 1First-in-human
5(6.4%)
Phase 1Safety & dosage
46(59.0%)
Phase 2Efficacy & side effects
20(25.6%)
Phase 3Large-scale testing
2(2.6%)
N/ANon-phased studies
5(6.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

74.3%

26 of 35 finished

Non-Completion Rate

25.7%

9 ended early

Currently Active

8

trials recruiting

Total Trials

78

all time

Status Distribution
Active(10)
Completed(26)
Terminated(9)
Other(33)

Detailed Status

unknown33
Completed26
Recruiting8
Terminated6
Withdrawn3
Enrolling by invitation2

Development Timeline

Analytics

Development Status

Total Trials
78
Active
8
Success Rate
81.3%
Most Advanced
Phase 3

Trials by Phase

Early Phase 15 (6.4%)
Phase 146 (59.0%)
Phase 220 (25.6%)
Phase 32 (2.6%)
N/A5 (6.4%)

Trials by Status

enrolling_by_invitation23%
terminated68%
withdrawn34%
recruiting810%
completed2633%
unknown3342%

Recent Activity

8 active trials
Showing 5 of 78
recruitingearly_phase_1

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

NCT06205342
terminatedphase_1

Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease

NCT04791878
terminatedphase_1

Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease

NCT04519684
terminatedphase_1

Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease

NCT04519697
terminatedphase_1

Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

NCT04519671
View all 78 trials

Clinical Trials (78)

Showing 20 of 78 trialsScroll for more
NCT06205342Early Phase 1

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

Recruiting
NCT04791878Phase 1

Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease

Terminated
NCT04519684Phase 1

Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease

Terminated
NCT04519697Phase 1

Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease

Terminated
NCT04519671Phase 1

Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

Terminated
NCT04047810Phase 1

Mesenchymal Stem Cells in the Treatment of Subjects With Advance Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT05925036Phase 1

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

Recruiting
NCT06570291Phase 3

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

Recruiting
NCT07039318Phase 2

Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

Completed
NCT06888973Phase 1

Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases

Enrolling By Invitation
NCT01606215Phase 1

Stem Cells in Rapidly Evolving Active Multiple Sclerosis

Completed
NCT06764329Phase 1

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

Enrolling By Invitation
NCT06727721Phase 2

Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus

Recruiting
NCT04506073Phase 2

Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease

Completed
NCT06514378Phase 1

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Recruiting
NCT06416709Phase 1

Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

Recruiting
NCT03356821Phase 1

Perinatal Arterial Stroke Treated With Stromal Cells Intranasally

Completed
NCT00603330Phase 2

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting
NCT06317818Phase 2

Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?

Recruiting
NCT02172885Phase 1

Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta

Completed

Drug Details

Intervention Type
DRUG
Total Trials
78